Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Company dossier
Eris Lifesciences
NSE:ERIS · ISIN INE406M01024
- Close
- ₹1,426.5 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Eris Lifesciences
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Eris Lifesciences LimitedNSE · conference call · pdf
Source filing Eris Lifesciences Ltd - 540596 - Financial Results For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Investor Presentation - Eris Lifesciences LimitedNSE · investor presentation · pdf
Source filing Outcome of Board Meeting - Eris Lifesciences LimitedNSE · financial results · pdf
Source filing Eris Lifesciences Ltd - 540596 - Board Meeting Outcome for Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Eris Lifesciences LimitedNSE · conference call · pdf
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Period Ended June 30, 2026BSE · financial results · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Eris Lifesciences LimitedNSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Trading Window - Eris Lifesciences LimitedNSE · exchange filing · pdf
Source filing ESOP/ESOS/ESPS - Eris Lifesciences LimitedNSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Updates - Eris Lifesciences LimitedNSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Corporate PresentationBSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD BSE · exchange filing · pdf
Source filing Updates - Eris Lifesciences LimitedNSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Imposition Of Fine By BSE Limited And National Stock Exchange Of India LimitedBSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - Eris Lifesciences LimitedNSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Eris Lifesciences LimitedNSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Eris Lifesciences LimitedNSE · conference call · pdf
Source filing Eris Lifesciences Ltd - 540596 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotBSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Shareholders meeting - Eris Lifesciences LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Eris Lifesciences LimitedNSE · conference call · pdf
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · exchange filing · pdf
Source filing Eris Lifesciences Ltd - 540596 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Date of payment of DividendBSE · corporate action · pdf
Source filing Eris Lifesciences Ltd - 540596 - Financial Results For The Quarter And Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Eris Lifesciences Ltd - 540596 - Board Meeting Outcome for Outcome Of Board MeetingBSE · exchange filing · pdf
Source filing Investor Presentation - Eris Lifesciences LimitedNSE · investor presentation · pdf
Source filing